Mogamulizumab-kpkc Intravenous and SPB11
Determining the interaction of Mogamulizumab-kpkc Intravenous and SPB11 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: sodium phenylbutyrate
Brand name: Buphenyl
Synonyms: Sodium phenylbutyrate, Sodium Phenylbutyrate Powder
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Specimen Collection Kit
- Mogamulizumab-kpkc Intravenous-Spectazole
- Mogamulizumab-kpkc Intravenous-Spectazole Topical
- Mogamulizumab-kpkc Intravenous-Spectracef
- Mogamulizumab-kpkc Intravenous-Spectro Tar Skin Wash Topical
- Mogamulizumab-kpkc Intravenous-Spiriva
- SPB11-Molindone
- SPB11-Mometasone (Oral Inhalation)
- SPB11-Mometasone and Formoterol
- SPB11-Mometasone and formoterol Inhalation
- SPB11-Mometasone Cream
- SPB11-Mometasone Furoate